// App-Quantinova.ai

e14527 : Imaging features of genomic instability in circulating tumor cells (CTCs) from metastatic triple-negative breast cancer (metTNBC) patients (pts) who received PIKTOR.

Researchers

Presenter

  • Priscilla Ontiveros

Principal Investigators

  • Maren K. Levin

  • Yipeng Wang

  • Beverly Hom

  • Ryan Dittamore

  • Joyce O'Shaughnessy

Medical Centers

  • Epic Sciences, Inc., San Diego, CA

  • Baylor Scott & White Research Institute, Dallas, TX

  • Epic Sciences, Inc., San Diego, CA

  • Baylor University Medical Center, Texas Oncology, Dallas, TX

Locations

  • United States

Companies

  • EPIC SCIENCES, INC.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Sapanisertib

  • Serabelisib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved